EICHOR
● Recruiting
A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell Disease
Condition: Sickle Cell Disease · Sponsor: Forma Therapeutics, Inc.
About this study
This study is being done to learn about etavopivat, a once a day medicine taken by mouth in adolescents with sickle cell disease. The main goals are to study safety and how long etavopivat stays in the bloodstream, while also studying if there are benefits from taking etavopivat. Eligible participants who enter the study will start a 96-week treatment period. At the end of the 96 weeks, participants will have an end of study visit that occurs 4 weeks later. The participants will receive etavopivat every day throughout the treatment period.
This description comes directly from the study's public registry record.
Talk to the study team
Novo Nordisk · (+1) 866-867-7178 · clinicaltrials@novonordisk.com
Always discuss trial participation with your own doctor first.
Locations (18)
| The Hospital for Sick Children | Toronto, Ontario, Canada | Withdrawn |
| APHP - Centre de Référence des Syndromes | Paris, France | Not Yet Recruiting |
| Hospices Civils de Lyon-Hopital Lyon Sud | Pierre-Bénite, France | Not Yet Recruiting |
| Centre Hospitalier Universitaire de Rouen-Hopital Charles Nicolle | Roeun, France | Not Yet Recruiting |
| KEMRI-Walter-Reed Kericho | Kericho, Kenya | Not Yet Recruiting |
| Kombewa Clinical Research Centre | Kisumu, Kenya | Not Yet Recruiting |
| Ahero Clinical Trials Unit | Kisumu, Kenya | Recruiting |
| Kenya Medical Research Institute-Centre for Respiratory Disease Research, Siaya Clinical Research Annexe | Siaya, Kenya | Not Yet Recruiting |
| American University of Beirut Medical center | Beirut, Lebanon | Recruiting |
| Hospital Nini | Tripoli, Lebanon | Recruiting |
| University of Nigeria Teaching Hospital (UNTH) | Ituku-Ozalla, Enugu State, Nigeria | Recruiting |
| Lagos University Teaching Hospital, Lagos | Lagos, Nigeria | Recruiting |
+ 6 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06198712